|Line 40:||Line 40:|
Revision as of 12:28, 30 May 2008
We are located in the new Cancer Research UK: Cambridge Research Institute. Our research goal is to understand the systems-level
transcriptional mechanisms underlying mammalian cell specification, which are often perturbed in carcinomas and diabetes,
using pancreatic beta-cells and liver hepatocytes as models.